News

Filter News By

Clear Filters

  1. CF Foundation Strongly Urges Universal Masking in Schools

    August 17, 2021

    The Cystic Fibrosis Foundation supports universal masking in school to protect people with CF and other health conditions against COVID-19.

  2. CF Foundation Launches Lung Transplant Biorepository and Patient Registry

    August 12, 2021

    The Cystic Fibrosis Lung Transplant Consortium Biorepository and Patient Registry, in collaboration with Cleveland Clinic, will provide critical clinical data and samples to support future research investigating complications of lung transplant.

  3. CF Foundation Announces 2021 Impact Grant Recipients

    July 26, 2021

    The Cystic Fibrosis Foundation announced the recipients of its sixth annual Impact Grants.

  4. Marc Ginsky, EVP and Chief Operating Officer, to Depart the Cystic Fibrosis Foundation

    July 15, 2021

    The Cystic Fibrosis Foundation announced that Executive Vice President and Chief Operating Officer, Marc Ginsky, will be leaving the CF Foundation this summer to pursue other opportunities.

    Topics:

  5. Cystic Fibrosis Foundation Announces Changes on Board of Trustees

    July 8, 2021

    The Foundation welcomes new members to its Board of Trustees to advance its mission, including Trustees Jessica Boyd, MD; Dominic J. Caruso; and Paul Motenko and advisors James R. Butler, II; Eric Schneider, MD; and Jennifer L. Taylor-Cousar, MD. Long-serving members Sue L. Hook and Ted J. Torphy, PhD, have retired from the Board.

    Topics:

  6. U.S. Supreme Court Rules on the Affordable Care Act

    June 17, 2021

    The Cystic Fibrosis Foundation celebrates the decision issued by the United States Supreme Court in California v. Texas, ultimately protecting the Affordable Care Act.

  7. CF Foundation Launches New Collaboration to Overcome Challenges to Developing Genetic Therapies for CF

    June 15, 2021

    Today, the Cystic Fibrosis Foundation announced a collaboration with Deep Science Ventures to accelerate treatments that address the underlying cause of CF for every person with the disease. The collaboration will focus on uncovering and designing new technologies to address key scientific challenges on the Path to a Cure.

  8. FDA Approves Trikafta for Children Ages 6 Through 11 With Certain Mutations

    June 9, 2021

    The U.S. Food and Drug Administration has approved the use of Trikafta ® (elexacaftor/tezacaftor/ivacaftor) for children ages 6 through 11 who have at least one copy of the F508del mutation or certain mutations in the CFTR gene that are responsive based on lab data. The U.S. Food and Drug Administrat

    Topics:

  9. First-of-Its-Kind Study Uses Smartphone to Track Cystic Fibrosis in Real Life

    June 2, 2021

    Observational study supported by the CF Foundation will monitor real-world experience with Trikafta

    Topics:

  10. CF Foundation Funds Three New Research Awards to Advance its Path to a Cure Initiative

    May 27, 2021

    New funding awards include up to $2.6M to Eloxx Pharmaceuticals to identify potential therapies for CF nonsense mutations

  11. CF Foundation Invests Up to $8.4M in SpliSense for the Development of Potential Rare Mutation Therapy

    May 13, 2021

    Today, the Cystic Fibrosis Foundation announced that it will invest up to $8.4 million in SpliSense’s Series B funding round to develop an antisense oligonucleotide therapy for people with cystic fibrosis who have splicing mutations and potentially other rare mutations.

  12. Molecular Analysis Identifies Key Differences in Lungs of People With Cystic Fibrosis

    May 6, 2021

    Researchers’ catalog of airway cell types could reveal targets for future genetic therapies

    Topics:

More Posts View All Posts

Related Content

Follow Us On